Management of antiplatelet therapy for non-elective invasive procedures or bleeding complications: Proposals from the French Working Group on Perioperative Haemostasis (GIHP) and the French Study Group on Thrombosis and Haemostasis (GFHT), in collaboration with the French Society for Anaesthesia and

[1]  K. Petro,et al.  Evaluating the effectiveness of pre-operative platelet inhibition testing to reduce costs and pre-operative length of stay. , 2018, Applied nursing research : ANR.

[2]  Y. Choi,et al.  Clopidogrel responsiveness regardless of the discontinuation date predicts increased blood loss and transfusion requirement after off-pump coronary artery bypass graft surgery. , 2010, Journal of the American College of Cardiology.

[3]  A. Civelek,et al.  Emergency coronary bypass surgery in patients under the influence of dualantiplatelet therapy: effects of tranexamic acid and desmopressin acetate , 2017, Turkish journal of medical sciences.

[4]  L. Valentino,et al.  Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[5]  S. Preisman,et al.  Modified thromboelastography evaluation of platelet dysfunction in patients undergoing coronary artery surgery. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  J. Teitelbaum,et al.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage , 2016, Neurocritical Care.

[7]  K. Karkouti,et al.  Can predicting transfusion in cardiac surgery help patients? , 2017, British journal of anaesthesia.

[8]  Saba Sarwar,et al.  National Confidential Enquiry into Patient Outcome and Death , 2007 .

[9]  P. Gennemark,et al.  Structural and functional characterization of a specific antidote for ticagrelor. , 2015, Blood.

[10]  M. Leone,et al.  Recommandations sur la réanimation du choc hémorragique , 2015 .

[11]  M. Ranucci,et al.  Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. , 2007, Journal of cardiothoracic and vascular anesthesia.

[12]  G. Taylor,et al.  Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery? , 2013, The journal of trauma and acute care surgery.

[13]  M. Ranucci,et al.  Multiple electrode whole-blood aggregometry and bleeding in cardiac surgery patients receiving thienopyridines. , 2011, The Annals of thoracic surgery.

[14]  P. Leprince,et al.  Efficacy of Ex Vivo Autologous and In Vivo Platelet Transfusion in the Reversal of P2Y12 Inhibition by Clopidogrel, Prasugrel, and Ticagrelor: The APTITUDE Study , 2015, Circulation. Cardiovascular interventions.

[15]  Dennis Y Kim,et al.  Risky business? Investigating outcomes of patients undergoing urgent laparoscopic appendectomy on antithrombotic therapy. , 2017, American journal of surgery.

[16]  Howard K. Song,et al.  2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. , 2012, The Annals of thoracic surgery.

[17]  L. Holmvang,et al.  Outcome After Surgery for Acute Aortic Dissection: Influence of Preoperative Antiplatelet Therapy on Prognosis. , 2017, Journal of cardiothoracic and vascular anesthesia.

[18]  Eric E. Smith,et al.  Association of Intracerebral Hemorrhage Among Patients Taking Non–Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality , 2018, JAMA.

[19]  A. Godier,et al.  Inefficacy of platelet transfusion to reverse ticagrelor. , 2015, The New England journal of medicine.

[20]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  C. Samama,et al.  Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrel , 2010, Thrombosis and Haemostasis.

[22]  A. Corsini,et al.  Pharmacology of the New P2Y12 Receptor Inhibitors: Insights on Pharmacokinetic and Pharmacodynamic Properties , 2013, Drugs.

[23]  P. Myles,et al.  Tranexamic Acid in Patients Undergoing Coronary‐Artery Surgery , 2017, The New England journal of medicine.

[24]  P. Wouters,et al.  Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: First update 2016. , 2017, European journal of anaesthesiology.

[25]  M. Alberts,et al.  Early Platelet Transfusion Improves Platelet Activity and May Improve Outcomes After Intracerebral Hemorrhage , 2012, Neurocritical Care.

[26]  C. Hesse,et al.  Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery , 2016, European Journal of Cardio-Thoracic Surgery.

[27]  C. Hesse,et al.  Effects of ex vivo platelet supplementation on platelet aggregability in blood samples from patients treated with acetylsalicylic acid, clopidogrel, or ticagrelor. , 2014, British journal of anaesthesia.

[28]  C. Samama,et al.  Use of factor concentrates for the management of perioperative bleeding: guidance from the SSC of the ISTH , 2018, Journal of thrombosis and haemostasis : JTH.

[29]  J. Stubbs,et al.  Reversing the Effects of Antiplatelet Agents in the Setting of Intracranial Hemorrhage , 2015, Journal of intensive care medicine.

[30]  E. Grove,et al.  Platelet function testing and prediction of procedural bleeding risk , 2013, Thrombosis and Haemostasis.

[31]  C. Patrono,et al.  Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. , 2017, Journal of the American College of Cardiology.

[32]  P. Gurbel,et al.  Platelet Function Testing Before CABG is Recommended in the Guidelines: But Do We Have Enough Evidence? , 2015, Journal of interventional cardiology.

[33]  T. Hohlfeld,et al.  Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers , 2014, Clinical pharmacology : advances and applications.

[34]  L. Cohn,et al.  Point-of-Care Testing: A Prospective, Randomized Clinical Trial of Efficacy in Coagulopathic Cardiac Surgery Patients , 2012, Anesthesiology.

[35]  M. Fredrikson,et al.  To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. , 2010, British journal of anaesthesia.

[36]  Rustam Al-Shahi Salman,et al.  Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial , 2016, The Lancet.

[37]  Deepak L. Bhatt,et al.  Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. , 2013, Journal of the American College of Cardiology.

[38]  Antonio Colombo,et al.  Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study , 2013, The Lancet.

[39]  S. Zehir,et al.  Early surgery is feasible in patients with hip fractures who are on clopidogrel therapy. , 2015, Acta orthopaedica et traumatologica turcica.

[40]  F. Tubach,et al.  Impact of preoperative maintenance or interruption of aspirin on thrombotic and bleeding events after elective non-cardiac surgery: the multicentre, randomized, blinded, placebo-controlled, STRATAGEM trial. , 2011, British journal of anaesthesia.

[41]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[42]  C. Négrier,et al.  Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response , 2016, Thrombosis and Haemostasis.

[43]  P. Fontana,et al.  Impact of non-inhibited platelet supplementation on platelet reactivity in patients treated with prasugrel or ticagrelor for an acute coronary syndrome: An ex vivo study , 2015, Platelets.

[44]  N. Curzen,et al.  Changes in platelet function with inflammation in patients undergoing vascular surgery , 2019, Platelets.

[45]  T. Kohlmann,et al.  Platelet transfusion to reverse antiplatelet therapy before decompressive surgery in patients with intracranial haemorrhage , 2017, Vox sanguinis.

[46]  A. Berghold,et al.  Platelet Inhibition and Bleeding in Patients Undergoing Non-Cardiac Surgery—The BIANCA Observational Study , 2018, Thrombosis and Haemostasis.

[47]  R. Teng,et al.  The effect of desmopressin on bleeding time and platelet aggregation in healthy volunteers administered ticagrelor , 2014, Journal of clinical pharmacy and therapeutics.

[48]  A. Hvas,et al.  Predictive Value of Whole Blood and Plasma Coagulation Tests for Intra- and Postoperative Bleeding Risk: A Systematic Review , 2017, Seminars in Thrombosis and Hemostasis.

[49]  K. Ghadimi,et al.  Perioperative management of the bleeding patient. , 2016, British journal of anaesthesia.

[50]  L. Laine,et al.  No Benefit From Platelet Transfusion for Gastrointestinal Bleeding in Patients Taking Antiplatelet Agents , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[51]  C. Soo,et al.  Clopidogrel and hip fractures, is it safe? A systematic review and meta-analysis , 2016, BMC Musculoskeletal Disorders.

[52]  F. Bonhomme.  Tests d’évaluation de la fonction plaquettaire délocalisés : un guide pour la transfusion de plaquettes ? , 2016 .

[53]  V. Deneer,et al.  Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation. , 2010, JAMA.

[54]  P. Dobesh,et al.  Ticagrelor: Pharmacokinetics, Pharmacodynamics, Clinical Efficacy, and Safety , 2014, Pharmacotherapy.

[55]  M. Mazzeffi,et al.  Perioperative management and monitoring of antiplatelet agents: a focused review on aspirin and P2Y12 inhibitors , 2017, Korean journal of anesthesiology.

[56]  C. Hesse,et al.  Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study. , 2016, British journal of anaesthesia.

[57]  P. Rhee,et al.  An acute care surgery dilemma: emergent laparoscopic cholecystectomy in patients on aspirin therapy. , 2015, American journal of surgery.

[58]  Thomas D. Scott,et al.  Does Preoperative Platelet Function Predict Bleeding in Patients Undergoing Off Pump Coronary Artery Bypass Surgery? , 2015, Journal of interventional cardiology.

[59]  P. Nurden,et al.  Bleeding risk of surgery and its prevention in patients with inherited platelet disorders , 2017, Haematologica.

[60]  A. Godier,et al.  Prise en charge du risque hémorragique associé aux agents antiplaquettaires , 2017 .

[61]  P. Mannucci.  Desmopressin: a nontransfusional form of treatment for congenital and acquired bleeding disorders. , 1988, Blood.

[62]  G. Landoni,et al.  Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta‐analysis of randomized controlled trials , 2017, Journal of thrombosis and haemostasis : JTH.

[63]  W. Vaughn,et al.  Clopidogrel and bleeding in patients undergoing elective coronary artery bypass grafting. , 2004, The Journal of thoracic and cardiovascular surgery.

[64]  A. Greinacher,et al.  Platelet transfusion for reversal of dual antiplatelet therapy in patients requiring urgent surgery: a pilot study , 2012, Journal of thrombosis and haemostasis : JTH.

[65]  P. Kolh,et al.  2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[66]  M. Laffan,et al.  Guideline on the management of bleeding in patients on antithrombotic agents , 2013, British journal of haematology.

[67]  B. Jilma,et al.  Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin. , 2003, Blood.

[68]  Paul J. Harrison,et al.  Aspirin twice a day keeps new COX‐1 at bay , 2012, Journal of thrombosis and haemostasis : JTH.

[69]  S. Susen,et al.  Management of antiplatelet therapy in patients undergoing elective invasive procedures. Proposals from the French Working Group on perioperative haemostasis (GIHP) and the French Study Group on thrombosis and haemostasis (GFHT). In collaboration with the French Society for Anaesthesia and Intensive , 2018, Anaesthesia, critical care & pain medicine.

[70]  C. Samama,et al.  The effectiveness of platelet supplementation for the reversal of ticagrelor-induced inhibition of platelet aggregation: An in-vitro study , 2016, European journal of anaesthesiology.

[71]  N. Schork,et al.  Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial. , 2011, JAMA.

[72]  C. Held,et al.  Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial. , 2011, Journal of the American College of Cardiology.

[73]  D. Abramowicz,et al.  Ticlopidine and clopidogrel, sometimes combined with aspirin, only minimally increase the surgical risk in renal transplantation: a case-control study. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[74]  J. Airaksinen,et al.  External Validation of the WILL-BLEED Risk Score. , 2018, Thrombosis and haemostasis.

[75]  P. Rehak,et al.  Platelet Function Measurement–Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing Coronary Artery Bypass Graft Surgery: The Timing Based on Platelet Function Strategy to Reduce Clopidogrel-Associated Bleeding Related to CABG (TARGET-CABG) Study , 2012, Circulation. Cardiovascular interventions.

[76]  S. Agarwal,et al.  Platelet function testing in cardiac surgery: A comparative study of electrical impedance aggregometry and thromboelastography , 2017, Platelets.

[77]  J. Vincent,et al.  The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition , 2016, Critical Care.

[78]  R. Altman,et al.  Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation , 2006, Journal of thrombosis and haemostasis : JTH.

[79]  A. Ferro,et al.  Comparative Pharmacokinetics and Pharmacodynamics of Platelet Adenosine Diphosphate Receptor Antagonists and their Clinical Implications , 2012, Clinical Pharmacokinetics.

[80]  B. Skolnick,et al.  Reversal of Clopidogrel-Induced Bleeding with rFVIIa in Healthy Subjects: A Randomized, Placebo-Controlled, Double-Blind, Exploratory Study , 2011, Anesthesia and analgesia.

[81]  John A. Evans,et al.  The management of antithrombotic agents for patients undergoing GI endoscopy. , 2016, Gastrointestinal endoscopy.

[82]  F. Granath,et al.  Platelet inhibition assessed with VerifyNow, flow cytometry and PlateletMapping in patients undergoing heart surgery. , 2009, Thrombosis research.

[83]  Helmut Baumgartner,et al.  ESC / EACTS Guidelines on myocardial revascularization , 2014 .

[84]  C. Samama,et al.  Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model , 2018, European journal of anaesthesiology.

[85]  V. Fuster,et al.  Platelet function normalization after a prasugrel loading‐dose: time‐dependent effect of platelet supplementation , 2013, Journal of thrombosis and haemostasis : JTH.

[86]  A. Hanke,et al.  First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. , 2011, Anesthesiology.

[87]  G. Theilmeier,et al.  Effect of Clopidogrel on Thrombus Formation in an Ex Vivo Parallel Plate Flow Chamber Model Cannot Be Reversed by Addition of Platelet Concentrates or vWF Concentrate , 2017, Anesthesia and analgesia.

[88]  D. Clement.  A randomised, blinded, trial of Clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996 .

[89]  P. Kamphuisen,et al.  Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents , 2011, Journal of thrombosis and haemostasis : JTH.

[90]  I. Xanthopoulou,et al.  Ticagrelor vs prasugrel one-month maintenance therapy: Impact on platelet reactivity and bleeding events , 2014, Thrombosis and Haemostasis.

[91]  S. Amin-Hanjani,et al.  Impact of Platelet Transfusion on Intracerebral Hemorrhage in Patients on Antiplatelet Therapy-An Analysis Based on Intracerebral Hemorrhage Score. , 2018, World neurosurgery.

[92]  P. Mannucci.  Desmopressin (DDAVP) in the treatment of bleeding disorders: the first 20 years. , 1997, Blood.

[93]  H. ten Cate,et al.  Determinants of agreement between proposed therapeutic windows of platelet function tests in vulnerable patients , 2017, European heart journal. Cardiovascular pharmacotherapy.

[94]  M. Rumpf,et al.  Reversibility of platelet P2Y12 inhibition by platelet supplementation: ex vivo and in vitro comparisons of prasugrel, clopidogrel and ticagrelor , 2018, Journal of thrombosis and haemostasis : JTH.

[95]  L. Alberio,et al.  The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects. , 2014, Blood.

[96]  A. McDonald,et al.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial , 2010, The Lancet.

[97]  P. Goodney,et al.  A Meta-analysis of the Impact of Aspirin, Clopidogrel, and Dual Antiplatelet Therapy on Bleeding Complications in Noncardiac Surgery , 2018, Annals of surgery.

[98]  R. Strasser,et al.  Reversal of the platelet inhibitory effect of the P2Y12 inhibitors clopidogrel, prasugrel, and ticagrelor in vitro: a new approach to an old issue , 2017, Clinical Research in Cardiology.

[99]  R. Frye,et al.  Perioperative Cardiovascular Risk of Prior Coronary Stent Implantation Among Patients Undergoing Noncardiac Surgery. , 2016, Journal of the American College of Cardiology.

[100]  C. la Vecchia,et al.  Time from adenosine di-phosphate receptor antagonist discontinuation to coronary bypass surgery in patients with acute coronary syndrome: meta-analysis and meta-regression. , 2013, International journal of cardiology.

[101]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[102]  P. Seferovic,et al.  [2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)]. , 2019, Giornale italiano di cardiologia.

[103]  K. Hansson,et al.  Boosting the coagulation restores haemostasis in ticagrelor-treated mice , 2016, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[104]  E. Hansson,et al.  Antiplatelet Therapy, Platelet Function Testing, and Bleeding Complications in Cardiac Surgery Patients , 2017, Seminars in Thrombosis and Hemostasis.

[105]  W. Ageno,et al.  A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2. , 2018, JACC. Cardiovascular interventions.

[106]  D. von Lewinski,et al.  Implementation of buffy‐coat‐derived pooled platelet concentrates for internal quality control of light transmission aggregometry: a proof of concept study , 2017, Journal of thrombosis and haemostasis : JTH.

[107]  Cornet Ad,et al.  Coronary stent occlusion after platelet transfusion: a case series. , 2007 .

[108]  L. Klein,et al.  Coronary stent occlusion after platelet transfusion: a case series. , 2007, The Journal of invasive cardiology.

[109]  L. Leong,et al.  Is Platelet Transfusion Effective in Patients Taking Antiplatelet Agents Who Suffer an Intracranial Hemorrhage? , 2015, The Journal of emergency medicine.

[110]  J. Hirsh,et al.  REVERSAL OF THE ANTI-PLATELET EFFECTS OF ASPIRIN AND CLOPIDOGREL , 2012, Heart.

[111]  M. Mazzeffi,et al.  In vitro effects of recombinant activated factor VII on thrombin generation and coagulation following inhibition of platelet procoagulant activity by prasugrel. , 2013, Thrombosis research.

[112]  A. Kappetein,et al.  Tranexamic Acid in Patients Undergoing Coronary-Artery Surgery. , 2018, The New England journal of medicine.

[113]  M. Wąsowicz,et al.  The role of point‐of‐care platelet function testing in predicting postoperative bleeding following cardiac surgery: a systematic review and meta‐analysis , 2015, Anaesthesia.

[114]  R. Peto,et al.  Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. , 2010, Lancet.

[115]  Volkmar Falk,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca , 2014, European heart journal.

[116]  B. Nair,et al.  Preoperative Low-Dose Aspirin Exposure and Outcomes After Emergency Neurosurgery for Traumatic Intracranial Hemorrhage in Elderly Patients , 2017, Anesthesia and analgesia.

[117]  E. Vicaut,et al.  Bedside monitoring to adjust antiplatelet therapy for coronary stenting. , 2012, The New England journal of medicine.

[118]  C. Divino,et al.  The evaluation of clopidogrel use in perioperative general surgery patients: a prospective randomized controlled trial. , 2016, American journal of surgery.

[119]  C. Samama,et al.  Non-cardiac surgery in patients with coronary stents: the RECO study , 2011, Heart.

[120]  F. Biglioli,et al.  Perioperative management of antiplatelet therapy in patients with coronary stents undergoing cardiac and non-cardiac surgery: a consensus document from Italian cardiological, surgical and anaesthesiological societies. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[121]  Zhaosheng Sun,et al.  Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage. , 2013, Journal of neurosurgery.

[122]  Phil Edwards,et al.  Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis , 2012, BMJ : British Medical Journal.

[123]  T. Warner,et al.  Newly Formed Reticulated Platelets Undermine Pharmacokinetically Short-Lived Antiplatelet Therapies , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[124]  G. Guyatt,et al.  Aspirin in Patients With Previous Percutaneous Coronary Intervention Undergoing Noncardiac Surgery , 2018, Annals of Internal Medicine.

[125]  Eric J. Ley,et al.  Novel oral anticoagulants and trauma: The results of a prospective American Association for the Surgery of Trauma Multi-Institutional Trial , 2017, The journal of trauma and acute care surgery.

[126]  M. Murphy,et al.  Rebleeding and Mortality After Lower Gastrointestinal Bleeding in Patients Taking Antiplatelets or Anticoagulants. , 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[127]  V. Fuster,et al.  Impact of Timing on the Functional Recovery Achieved With Platelet Supplementation After Treatment With Ticagrelor , 2017, Circulation. Cardiovascular interventions.

[128]  S. Diamond,et al.  Microfluidic whole blood testing of platelet response to pharmacological agents , 2017, Platelets.